Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics, Palacky University Partner on Thyroid Cancer Dx

NEW YORK (GenomeWeb) — Rosetta Genomics said today that it is collaborating with the Institute of Molecular Translational Medicine (IMTM) at Palacky University in the Czech Republic to validate and develop a new thyroid cancer diagnostic tool.

Under the agreement, Rosetta and IMTM will work toward improving the diagnosis of malignant tumors in suspected thyroid cancer patients by connecting expertise and clinical samples at IMTM with Rosetta's microRNA platform technology and product development expertise.

"Our initial studies have demonstrated that microRNA expression levels can differentiate malignant nodules from benign nodules, and also demonstrated the ability to extract and profile microRNAs from thyroid FNAs," Rosetta President and CEO Kenneth Berlin said in a statement. "The access to IMTM's thyroid cancer samples and translation research should enhance and accelerate the larger validating studies we have underway, as we plan for a third quarter 2015 launch of our thyroid assay in the US."

The partnership is being facilitated by the European Infrastructure for Translational Medicine (EATRIS), a recently established business model designed to bring together industry and academia. EATRIS comprises leading academic groups and institutions in eight countries that provide access to translational research infrastructure and expertise.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.